Cushing Asset Management, LP Alnylam Pharmaceuticals, Inc. Transaction History

Cushing Asset Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $325,013 - $456,913	-2,699 Reduced 48.89%	2,821 $411,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $38,281 - $52,346	-301 Reduced 5.17%	5,520 $901,000
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $61,111 - $80,158	-383 Reduced 6.17%	5,821 $987,000
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $23,934 - $29,289	-141 Reduced 2.22%	6,204 $1.17 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $20,580 - $28,302	-160 Reduced 2.46%	6,345 $1.08 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $183,649 - $254,399	1,448 Added 28.63%	6,505 $918,000
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $10,944 - $13,083	89 Added 1.79%	5,057 $657,000
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $8,240 - $11,253	68 Added 1.39%	4,968 $723,000
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $66,381 - $99,652	-637 Reduced 11.5%	4,900 $726,000
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $108,857 - $156,634	-1,169 Reduced 17.43%	5,537 $603,000
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $7,376 - $12,298	99 Added 1.5%	6,706 $772,000
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $468,436 - $580,226	6,607 New	6,607 $531,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Cushing Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cushing Asset Management, LP with notifications on news.